What’s new in prostate cancer
This webinar focuses on what's new in the diagnosis and management of early prostate cancer, as well as an update in the new drug therapies for advanced prostate cancer.
Describe in what circumstances a multiparametric MRI should be ordered for suspected early prostate cancer
List the biomarker tests that may help define ‘clinically significant’ prostate cancer
Describe the mechanism of action of the new hormonal agents for prostate cancer
List the common side effects of these agents and describe how the side effects can be managed
This event attracts 2 CPD points